Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...


Jen Farmer

This email address is being protected from spambots. You need JavaScript enabled to view it.

Chief Executive Officer

Title Created Date Category
Agilis Biotherapeutics Announces Orphan Product Designation Approval in Europe for the Treatment of Friedreich Ataxia Tuesday, October 31, 2017 Scientific News
Can rehabilitation improve the health and well-being in Friedreich's ataxia: a randomized controlled trial? Monday, October 30, 2017 Funded Research
Transplantation of wild-type mouse hematopoietic stem and progenitor cells ameliorates deficits in a mouse model of Friedreich's ataxia Monday, October 30, 2017 Scientific News
Friedreich's ataxia: clinical features, pathogenesis and management Tuesday, October 24, 2017 Scientific News
Nrf2-Inducers Counteract Neurodegeneration in Frataxin-Silenced Motor Neurons: Disclosing New Therapeutic Targets for Friedreich's Ataxia Tuesday, October 24, 2017 Scientific News
Reata Announces First Patient Enrolled in Part 2 of MOXIe Study of Omaveloxolone for the Treatment of Friedreich’s Ataxia Monday, October 23, 2017 Scientific News
Friedreich Ataxia: Developmental Failure of the Dorsal Root Entry Zone Thursday, October 19, 2017 Scientific News
Sustained FXN expression in dorsal root ganglia from a nonreplicative genomic HSV-1 vector Thursday, October 19, 2017 Scientific News
BioMarin Highlights Breadth of Innovative Development Pipeline at R&D Day on Oct 18th in New York Wednesday, October 18, 2017 Scientific News
CRISPR Therapeutics Awarded Grant from FARA to Collaborate with University of Alabama at Birmingham on Gene-edited Treatments for Friedreich’s Ataxia Friday, October 13, 2017 Funded Research


Site Map     Privacy Policy      Service Terms      Contact      Charity Navigator